Breaking News Instant updates and real-time market news.

NTRA

Natera

$20.58

0.31 (1.53%)

16:10
04/16/19
04/16
16:10
04/16/19
16:10

Natera files $100M common stock shelf

  • 16

    May

  • 28

    May

NTRA Natera
$20.58

0.31 (1.53%)

03/11/19
PIPR
03/11/19
NO CHANGE
Target $23
PIPR
Overweight
Natera partnership removes financing risk through 2020, says Piper Jaffray
Piper Jaffray analyst William Quirk says he likes the "non-dilutive funding" from Natera's 10-year partnership agreement with BGI Genomics and believes the deal removes the company's financing risk through at least 2020. Further, BGI is a major sequencing provider in China and this deal immediately expands Natera's access to this large market, Quirk tells investors in a research note. This "looks like a smart deal for both parties," says Quirk, who reiterates an Overweight rating on Natera with a $23 price target.
03/28/19
RAJA
03/28/19
NO CHANGE
RAJA
Strong Buy
CareDx lawsuit against Natera 'not unexpected,' says Raymond James
Raymond James analyst John Hsu notes that CareDx (CDNA) announced the filing of a patent infringement lawsuit against Natera (NTRA), which was "not unexpected." The analyst sees the lawsuit as consistent with management seeking to protect the company's intellectual property, and notes that the court process could take up to three years. While this lawsuit is a "logical course of action," Hsu believes CareDx remains focused on building its moat in kidney transplant, with sales force investments and a focus on integration with hospital electronic medical records. Overall, the analyst still views 2019's main focus on other activities to strengthen a "significant head start on the back of a best-in-class product launch in 2018." He reiterates a Strong Buy rating on CareDx shares.
03/29/19
ADAM
03/29/19
NO CHANGE
Target $27
ADAM
Buy
Natera draft local coverage decision a 'positive surprise,' says Canaccord
Canaccord analyst Mark Massaro said he was positively surprised that Natera was issued a draft local coverage decision by Palmetto MolDx for its blood-based kidney transplant rejection test, as he sees the news increasing the probability that the test launches with Medicare reimbursement. Even after yesterday's move higher on this news, Natera shares trade at a "material disconnect" to what the business is actually worth, Massaro contends. He raised his price target on the stock to $27 from $26 and keeps a Buy rating on Natera, adding that the stock "is at the top of our list of top picks for 2019."
04/04/19
BARD
04/04/19
NO CHANGE
Target $24
BARD
Outperform
Natera remains 'top idea' following management meetings, says Baird
Baird analyst Catherine Ramsey Schulte maintained an Outperform rating and $24 price target on Natera, saying she continues to recommend Natera as a top idea following recent investor meetings with CEO Steve Chapman and CFO Mike Brophy. The analyst thinks Natera's core business is healthy and believes transplant and oncology opportunities are only partially valued in the stock today and could drive meaningful upside over the next few years.

TODAY'S FREE FLY STORIES

NTB

Butterfield

$37.30

-0.18 (-0.48%)

06:13
04/25/19
04/25
06:13
04/25/19
06:13
Earnings
Butterfield reports Q1 EPS 96c, consensus 88c »

Net interest margin for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 30

    Apr

WNS

WNS Holdings

$56.45

0.73 (1.31%)

06:12
04/25/19
04/25
06:12
04/25/19
06:12
Earnings
WNS Holdings reports Q4 adjusted EPS 73c, consensus 68c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 23

    May

NOK

Nokia

$5.78

-0.015 (-0.26%)

06:12
04/25/19
04/25
06:12
04/25/19
06:12
Earnings
Nokia sees FY19 EPS EUR 0.25-EUR 0.29 »

Sees FY19 non-IFRS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 20

    May

FB

Facebook

$182.64

-1.13 (-0.61%)

06:12
04/25/19
04/25
06:12
04/25/19
06:12
Upgrade
Facebook upgraded to Buy from Neutral at UBS »

UBS analyst Eric Sheridan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

WCN

Waste Connections

$89.28

0.01 (0.01%)

06:11
04/25/19
04/25
06:11
04/25/19
06:11
Upgrade
Waste Connections rating change  »

Waste Connections…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 05

    May

  • 17

    May

  • 05

    Jun

SMMF

Summit Financial Group

$26.05

-0.2 (-0.76%)

06:11
04/25/19
04/25
06:11
04/25/19
06:11
Earnings
Summit Financial Group reports Q1 EPS 56c, consensus 54c »

Net interest margin for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

CRR

CARBO Ceramics

$3.35

-0.01 (-0.30%)

06:11
04/25/19
04/25
06:11
04/25/19
06:11
Earnings
Breaking Earnings news story on CARBO Ceramics »

CARBO Ceramics backs FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 21

    May

NOK

Nokia

$5.78

-0.015 (-0.26%)

06:10
04/25/19
04/25
06:10
04/25/19
06:10
Earnings
Nokia reports Q1 EPS (EUR 0.02) vs. EUR 0.02 last year »

Reports Q1 revenue EUR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 20

    May

PRLB

Proto Labs

$117.21

3.29 (2.89%)

06:10
04/25/19
04/25
06:10
04/25/19
06:10
Earnings
Proto Labs reports Q1 non-GAAP EPS 69, consensus 70c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 15

    May

  • 16

    May

  • 28

    May

  • 28

    May

  • 05

    Jun

CRR

CARBO Ceramics

$3.35

-0.01 (-0.30%)

06:09
04/25/19
04/25
06:09
04/25/19
06:09
Earnings
CARBO Ceramics reports Q1 EPS (73c), consensus (55c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 21

    May

XEL

Xcel Energy

$55.44

0.27 (0.49%)

06:09
04/25/19
04/25
06:09
04/25/19
06:09
Earnings
Breaking Earnings news story on Xcel Energy »

Xcel Energy backs 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 21

    May

  • 17

    Jun

XCEL

EXCEL ENERGY INC.

$0.00

(0.00%)

06:08
04/25/19
04/25
06:08
04/25/19
06:08
Earnings
Excel Energy reports Q1 EPS 61c, consensus 61c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WST

West Pharmaceutical

$115.19

(0.00%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Earnings
West Pharmaceutical raises FY19 adj. EPS view to $2.80-$2.90 from $2.77-$2.89 »

Consensus $2.86. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

IRM

Iron Mountain

$35.84

-0.025 (-0.07%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Earnings
Breaking Earnings news story on Iron Mountain »

Iron Mountain sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

  • 04

    Jun

BDRBF

Bombardier

$0.00

(0.00%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Earnings
Bombardier cuts FY19 revenue view to about $17B, consensus $16.26B »

Consolidated revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

  • 05

    Jun

NTB

Butterfield

$37.30

-0.18 (-0.48%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Hot Stocks
Butterfield to acquire ABN AMRO Channel Islands for approximately $208M »

The Bank of N.T.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 30

    Apr

WST

West Pharmaceutical

$115.19

(0.00%)

06:06
04/25/19
04/25
06:06
04/25/19
06:06
Earnings
West Pharmaceutical reports Q1 adj. EPS 74c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

ENTG

Entegris

$40.85

0.18 (0.44%)

06:06
04/25/19
04/25
06:06
04/25/19
06:06
Earnings
Entegris sees Q2 non-GAAP EPS 40c-45c, consensus48c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 28

    May

WCN

Waste Connections

$89.28

0.01 (0.01%)

06:05
04/25/19
04/25
06:05
04/25/19
06:05
Upgrade
Waste Connections rating change  »

Waste Connections…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 05

    May

  • 17

    May

  • 05

    Jun

BDRBF

Bombardier

$0.00

(0.00%)

06:05
04/25/19
04/25
06:05
04/25/19
06:05
Earnings
Bombardier sees Q1 revenue about $3.5B, consensus $4.76B »

Revenues for Q1 are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

  • 05

    Jun

IRM

Iron Mountain

$35.84

-0.025 (-0.07%)

06:05
04/25/19
04/25
06:05
04/25/19
06:05
Earnings
Iron Mountain reports Q1 adj. EPS 17c, consensus 24c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

  • 04

    Jun

ENTG

Entegris

$40.85

0.18 (0.44%)

06:04
04/25/19
04/25
06:04
04/25/19
06:04
Recommendations
Entegris analyst commentary  »

Entegris reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 28

    May

PTEN

Patterson-UTI

$15.13

-0.71 (-4.48%)

06:04
04/25/19
04/25
06:04
04/25/19
06:04
Earnings
Patterson-UTI reports Q1 EPS (14c), consensus (21c) »

Reports Q1 revenue $704M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

TER

Teradyne

$47.99

3.39 (7.60%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Upgrade
Teradyne rating change  »

Teradyne upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 29

    May

VMI

Valmont

$132.99

1.845 (1.41%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Upgrade
Valmont rating change  »

Valmont upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 24

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.